olfactory receptor family 10 subfamily V member 3 pseudogeneGenealiases: []
Q-omics provides the consensus-scored OR10V3P profile across patient tissues and cancer cell-line models. OR10V3P expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in ESCA. Among the 18 cancer types available for tumor–normal comparison, OR10V3P is differentially expressed in 5, with the highest sampling consensus in HNSC. Additionally, OR10V3P RNA expression shows 8,621 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight ESCA, HNSC, and UVM as cancer lineages where OR10V3P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR10V3P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR10V3P survival associations across molecular data types. OR10V3P RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR10V3P RNA expression–survival associations across cancer types. High OR10V3P expression shows unfavorable associations in HNSC, KIRC, STAD and GBM, but favorable associations in ESCA and ACC. The ESCA Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify ESCA as the clearest survival context for OR10V3P RNA expression.
This table summarizes OR10V3P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for OR10V3P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR10V3P shows lower tumor expression in BRCA and higher tumor expression in HNSC, KIRC, KIRP and KICH. The HNSC box plot shows higher OR10V3P RNA expression in tumor versus normal tissue (log2 FC = +0.155, t-test p < 0.001).
This table shows molecular features associated with OR10V3P in patient tissues and cancer cell lines. In patient samples, OR10V3P shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
